PubMed , European Journal of Pharmacology , vol
Receptor for advanced glycation endproducts (RAGE): A formidable force in the pathogenesis of the cardiovascular complications of diabetes & aging
Common locations for GLP-1 medication-related cramps: Calf muscles : Frequently reported, especially nocturnal cramps Feet and toes : Often presenting as painful curling or spasms Thigh muscles : Less commonly affected but reported by some patients Abdominal muscles : May be confused with digestive side effects Hands : Occasionally reported, especially with electrolyte imbalances Cramp characteristics: Duration : Typically last from a few seconds to several minutes Intensity : Range from mild tightness to painful spasms Timing : More common at night or after physical activity Trigger patterns : May increase after dose increases or with dehydration Online patient discussions reveal significant individual variation in cramping experiences
Under the shown conditions using hydroformylation process HFP-1, the model substrate 2SM furnished the corresponding allysine 2A (read-out via thioacetal 2B ) in 91% yield, with 96% conversion of 2SM
Some researchers and clinicians advocate for the higher end of this range, up to 2.4 grams per kilogram, when fasting is combined with caloric restriction and GLP-1 therapy
